Epigenetic stability of human pluripotent stem cells

Epigenomics: From Chromatin Biology to Therapeutics

Volumn , Issue , 2012, Pages 118-133

  Vallot, Céline ^a   Rougeulle, Claire ^a  

^a Université Sorbonne Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923498135     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511777271.013     Document Type: Chapter

References (63)

1. Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology, 25, 803—816.
2. Allegrucci, C., Wu, Y. Z., Thurston, A., et al. (2007). Restriction landmark genome scanning identifies culture-induced DNA methylation instability in the human embryonic stem cell epigenome. Human Molecular Genetics, 16, 1253—1268.
3. Baker, D. E., Harrison, N. J., Maltby, E., et al. (2007). Adaptation to culture of human embry-onic stem cells and oncogenesis in vivo. Nature Biotechnology, 25, 207—215.
4. Bibikova, M., Chudin, E., Wu, B., et al. (2006). Human embryonic stem cells have a unique epigenetic signature. Genome Research, 16, 1075—1083.
5. Brown, C. J., Ballabio, A., Rupert, J. L., et al. (1991). A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature, 349, 38—44.
6. Calvanese, V., Horrillo, A., Hmadcha, A., et al. (2008). Cancer genes hypermethylated in human embryonic stem cells. PLoS One, 3, e3294.
7. Chamberlain, S. J., Yee, D., and Magnuson, T. (2008). Polycomb repressive complex 2 is dispensable for maintenance of embryonic stem cell pluripotency. Stem Cells, 26, 1496—1505.
8. Chamberlain, S. J., Chen, P. F., Ng, K. Y., et al. (2010). Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader—Willi syndromes. Proceedings of the National Academy of Sciences USA, 107, 17 668—17 673.
9. Chin, M.H., Mason, M. J., Xie, W., et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell, 5, 111—123.
10. Chow, J. and Heard, E. (2009). X inactivation and the complexities of silencing a sex chromosome. Current Opinion in Cell Biology, 21, 359—366.
11. Christophersen, N. S. and Helin, K. (2010). Epigenetic control of embryonic stem cell fate. Journal of Experimental Medicine, 207, 2287—2295.
12. Cooper, W.N., Luharia, A., Evans, G. A., et al. (2005). Molecular subtypes and phenotypic expression of Beckwith—Wiedemann syndrome. European Journal of Human Genetics, 13, 1025—1032.
13. Cox, G. F., Burger, J., Lip, V., et al. (2002). Intracytoplasmic sperm injection may increase the risk of imprinting defects. American Journal of Human Genetics, 71, 162—164.
14. Daniels, R., Zuccotti, M., Kinis, T., et al. (1997). Xist expression in human oocytes and preimplantation embryos. American Journal of Human Genetics, 61, 33—39.
15. Deng, J., Shoemaker, R., Xie, B., et al. (2009). Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nature Biotechnology, 27, 353—360.
16. Dhara, S. K. and Benvenisty, N. (2004). Gene trap as a tool for genome annotation and analysis of X chromosome inactivation in human embryonic stem cells. Nucleic Acids Research, 32, 3995—4002.
17. Frost, J. M., Monk, D., Moschidou, D., et al. (2011). The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells. Epigenetics, 6, 52—62.
18. Ghosh, Z., Wilson, K. D., Wu, Y., et al. (2010). Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embry-onic stem cells. PLoS One, 5, e8975.
19. Guenther, M. G., Levine, S. S., Boyer, L. A., et al. (2007). A chromatin landmark and transcription initiation at most promoters in human cells. Cell, 130, 77—88.
20. Guenther, M. G., Frampton, G. M., Soldner, F., et al. (2010). Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell, 7, 249—257.
21. Hall, L. L., Byron, M., Butler, J., et al. (2008). X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. Journal of Cell Physiology, 216, 445—452.
22. Hanna, J., Cheng, A. W., Saha, K., et al. (2010). Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proceedings of the National Academy of Sciences USA, 107, 9222—9227.
23. Hawkins, R. D., Hon, G. C., Lee, L. K., et al. (2010). Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell, 6, 479—491.
24. Hoffman, L. M., Hall, L., Batten, J. L., et al. (2005). X-inactivation status varies in human embryonic stem cell lines. Stem Cells, 23, 1468—1478.
25. Horsthemke, B. and Buiting, K. (2008). Genomic imprinting and imprinting defects in humans. Advances in Genetics, 61, 225—246.
26. Huntriss, J. and Picton, H. M. (2008). Stability of genomic imprinting in embryonic stem cells: lessons from assisted reproductive technology. Current Stem Cell Research and Therapy, 3, 107—16.
27. Huntriss, J., Daniels, R., Bolton, V., et al. (1998). Imprinted expression of SNRPN in human preimplantation embryos. American Journal of Human Genetics, 63, 1009—1014.
28. Kawakami, T., Zhang, C., Taniguchi, T., et al. (2004). Characterization of loss-of-inactiveXin Klinefelter syndrome and female-derived cancer cells. Oncogene, 23, 6163—6169.
29. Kim, K. P., Thurston, A., Mummery, C., et al. (2007). Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Research, 17, 1731—1742.
30. Lagarkova, M. A., Shutova, M. V., Bogomazova, A. N., et al. (2010). Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle, 9, 937—946.
31. Laurent, L., Wong, E., Li, G., et al. (2010). Dynamic changes in the human methylome during differentiation. Genome Research, 20, 320—331.
32. Lengner, C. J., Gimelbrant, A. A., Erwin, J. A., et al. (2010). Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell, 141, 872—883.
33. Lighten, A. D., Hardy, K., Winston, R. M., et al. (1997). IGF2 is parentally imprinted in human preimplantation embryos. Nature Genetics, 15, 122—123.
34. Lister, R., Pelizzola, M., Dowen, R. H., et al. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462, 315—322.
35. Luedi, P. P., Dietrich, F. S., Weidman, J. R., et al. (2007). Computational and experimental identification of novel human imprinted genes. Genome Research, 17, 1723—1730.
36. Maitra, A., Arking, D. E., Shivapurkar, N., et al. (2005). Genomic alterations in cultured human embryonic stem cells. Nature Genetics, 37, 1099—1103.
37. Marchetto, M. C., Yeo, G. W., Kainohana, O., et al. (2009). Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One, 4, e7076.
38. Marchetto, M. C., Carromeu, C., Acab, A., et al. (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143, 527—539.
39. Meissner, A. (2010). Epigenetic modifications in pluripotent and differentiated cells. Nature Biotechnology, 28, 1079—1088.
40. Moreira de Mello, J. C., de Araujo, E. S., Stabellini, R., et al. (2010). Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PLoS One, 5, e10947.
41. O'Carroll, D., Erhardt, S., Pagani, M., et al. (2001). The Polycomb-group gene Ezh2 is required for early mouse development. Molecular Cell Biology, 21, 4330—4336.
42. Okano, M., Bell, D. W., Haber, D. A., et al. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247—257.
43. Orstavik, K. H., Eiklid, K., van der Hagen, C. B., et al. (2003). Another case of imprinting defect in a girl with Angelman syndrome who was conceived by intracytoplasmic semen injection. American Journal of Human Genetics, 72, 218—219.
44. Pan, G., Tian, S., Nie, J., et al. (2007). Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell, 1, 299—312.
45. Penny, G. D., Kay, G. F., Sheardown, S. A., et al. (1996). Requirement for Xist in X chromosome inactivation. Nature, 379, 131—137.
46. Pick, M., Stelzer, Y., Bar-Nur, O., et al. (2009). Clone-and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells, 27, 2686—2690.
47. Ray, P. F., Winston, R. M., and Handyside, A. H. (1997). Xist expression from the maternal X chromosome in human male preimplantation embryos at the blastocyst stage. Human Molecular Genetics, 6, 1323—1327.
48. Rugg-Gunn, P. J., Ferguson-Smith, A. C., and Pedersen, R. A. (2005). Epigenetic status of human embryonic stem cells. Nature Genetics, 37, 585—587.
49. Rugg-Gunn, P. J., Ferguson-Smith, A. C., and Pedersen, R. A. (2007). Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines. Human Molecular Genet, 16 Spec. No. 2, R243—51.
50. Salpekar, A., Huntriss, J., Bolton, V., et al. (2001). The use of amplified cDNA to investigate the expression of seven imprinted genes in human oocytes and preimplantation embryos. Molecular Human Reproduction, 7, 839—844.
51. Shen, Y., Chow, J., Wang, Z., et al. (2006). Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Human Molecular Genetics, 15, 2623—2635.
52. Shen, Y., Matsuno, Y., Fouse, S. D., et al. (2008). X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proceedings of the National Academy of Sciences USA, 105, 4709—4714.
53. Silva, S. S., Rowntree, R. K., Mekhoubad, S., et al. (2008). X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proceedings of the National Academy of Sciences USA, 105, 4820—4825.
54. Smiraglia, D. J., Rush, L. J., Fruhwald, M. C., et al. (2001). Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Human Molecular Genetics, 10, 1413—1419.
55. Sun, B. W., Yang, A. C., Feng, Y., et al. (2006). Temporal and parental-specific expression of imprinted genes in a newly derived Chinese human embryonic stem cell line and embryoid bodies. Human Molecular Genetics, 15, 65—75.
56. Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861—872.
57. Tanasijevic, B., Dai, B., Ezashi, T., et al. (2009). Progressive accumulation of epigenetic heterogeneity during human ES cell culture. Epigenetics, 4, 330—338.
58. Tchieu, J., Kuoy, E., Chin, M. H., et al. (2010). Female human iPSCs retain an inactive X chromosome. Cell Stem Cell, 7, 329—342.
59. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145—1147.
60. Tsumura, A., Hayakawa, T., Kumaki, Y., et al. (2006). Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes to Cells, 11, 805—814. van den Berg, I. M., Laven, J. S., Stevens, M., et al. (2009). X chromosome inactivation is initiated in human preimplantation embryos. American Journal of Human Genetics, 84, 771—779.
61. Xie, W., Song, C., Young, N. L., et al. (2009).HistoneH3lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Molecular Cell, 33, 417—427.
62. Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917—1920.
63. Zhao, X. D., Han, X., Chew, J. L., et al. (2007). Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell, 1, 286—298.